Delivery Order SPE2DB20D3103-SPE2DB25FQ1U6
Award Date 9/5/25
Potential Completion Date 9/8/25
Potential Value $6.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $47,320.66 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units). This competitive award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $23,157.77 to AmerisourceBergen Drug Corp for the supply of Dasatinib 80 mg tablets (30-count units) under a firm fixed-price contract type. The order was competitively awarded without set-aside designation and carries an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units) under a firm fixed-price contract valued at $33,764.34, with completion targeted for September 26, 2025. This competitively awarded, non-set-aside delivery order represents a continuation of the vendor's role as a critical pharmaceutical supplier to the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,744.14 to AmerisourceBergen Drug Corp for the supply of Dasatinib 140 mg tablets (30-count units) on September 23, 2025, with an ultimate completion date of September 24, 2025. The contract employs firm fixed pricing under a non-competitive, non-set-aside delivery order structure. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,448.37 to AmerisourceBergen Drug Corp for the supply of Dasatinib 80 mg tablets (30-count units) with an ultimate completion date of August 5, 2025. The contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency's Medical Supply Chain awarded a $43,070.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Dasatinib 100 mg on September 15, 2025. The contract, which is non-set-aside and competitively awarded, specifies a place of performance in Conshohocken, Pennsylvania and an ultimate completion date of September 16, 2025. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's existing contract vehicle with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dasatinib 20 mg tablets (60-count units) with a ceiling value of $2,077.39. This is a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The contract was competitively awarded with no set-aside designation and is being...
- The Defense Logistics Agency awarded a $25,721.56 delivery order to AmerisourceBergen Drug Corp for Dasatinib 80 mg tablets in a 30-count supply on September 25, 2025, with completion scheduled for September 26, 2025. This competitive, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The place...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Dasatinib 100 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $37,364.76, with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dasatinib 70 mg tablets (60-count units) under a firm fixed-price contract valued at $4,583.27, with an ultimate completion date of September 29, 2025. This non-set-aside delivery order represents a competitive award to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. The order is a child contract under...